Free. Unsubscribe any time.
Contineum Therapeutics, Inc. (CTNM)
Contineum Therapeutics, Inc. filed 21 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 3 reporting owners, covering 30 transactions and 122,299 shares. None carries the SEC's AFF10B5ONE flag; all 21 name a plan in a footnote. No results print is on file in this window, so no interval is measured.
What stands out
- The most recent filing on file, dated 2026-09-08, came 36 days after the one before it (2026-08-03) and reports 3 transactions against 3 in the filing before it.
- The sales it reports total 2,500 shares, the same as the 2,500 in the filing before it.
- Its 21 filings on file run from 2025-12-30 to 2026-09-08, and state one plan adoption date, 2025-09-23.
Trades in Contineum Therapeutics, Inc. 30
- Lorrain Daniel S. — 2025-12-23 · S · 4,170 shares
- Watkins Tim — 2025-12-29 · S · 3,611 shares
- Lorrain Daniel S. — 2026-01-05 · S · 3,670 shares
- Lorrain Daniel S. — 2026-01-05 · S · 500 shares
- Watkins Tim — 2026-01-28 · S · 2,800 shares
- Watkins Tim — 2026-01-28 · S · 811 shares
- Lorrain Daniel S. — 2026-02-03 · S · 3,000 shares
- Lorrain Daniel S. — 2026-02-03 · S · 1,170 shares
- Lorrain Daniel S. — 2026-02-11 · S · 400 shares
- Lorrain Daniel S. — 2026-02-19 · S · 100 shares
- Lorrain Daniel S. — 2026-02-24 · S · 4,300 shares
- Stengone Carmine N. — 2026-02-24 · S · 4,400 shares
Adoption dates in Contineum Therapeutics, Inc. 1
- 2025-09-23 — stated in 21 filings
Results prints in Contineum Therapeutics, Inc. 0
Trades before a print in Contineum Therapeutics, Inc. 0
Interval to Contineum Therapeutics, Inc.’s next reported results date
How the interval and sources are counted →
- 0within 5 days
- 0within 10 days
- —shortest, days
- 30no later print
Adoption dates Contineum Therapeutics, Inc. states
- 2025-09-23 in 21 filings
Filing text: “10b5-1 trading plan adopted by the reporting person on September 23, 2025”
Sources: SEC EDGAR full-text search and the SEC submissions API.